Empyema thoracis

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Volumn 4, Issue 1, 2010, Pages 1-8

  Ahmed, Ala Eldin H ^a,b   Yacoub, Tariq E ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b Elshaab Teaching Hospital   (Sudan)

Author keywords

Drainage; Empyema; Intrapleural fibrinolysis; Management; Surgery

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; DEOXYRIBONUCLEASE; GLUCOSE; MEROPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

BACTEROIDES FRAGILIS; CHILD CARE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DISEASE COURSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DYSPNEA; EMPYEMA; ESCHERICHIA COLI; FEVER; FIBRINOLYSIS; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; INCIDENCE; KLEBSIELLA PNEUMONIAE; LUNG SURGERY; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MORTALITY; PH; PLEURA EFFUSION; PLEURISY; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; THORAX DRAINAGE; THORAX PAIN; THORAX SURGERY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 77955391399     PISSN: None     EISSN: 11795484     Source Type: Journal    
DOI: 10.4137/ccrpm.s5066     Document Type: Review

References (55)

1. Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and longterm survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160:1682-7.
2. Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. Empyema subcommittee of the Research Committee of the British Thoracic Society. The clinical course and management of thoracic empyema. Q J Med. 1996;89:285-9.
3. Mandal AK, Thadepalli H, Mandal AK, Chettipally U. Outcome of primary empyema thoracic: therapeutic and microbiological aspects. Ann Thorac Surg. 1998;66:1782-6.
4. Ashbaugh DG. Empyema thoracis. Factors influencing morbidity and mortality. Chest. 1991;99:1162-5.
5. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med. 1980;69:507-12.
6. Rees JHM, Spencer DA, Parikh D, Weller P. Increase in incidence of childhood empyema in West Midlands, UK [Research Letters]. Lancet. 1997;349:402.
7. Gupta R, Crowley S. Increasing paediatric empyema admissions [Letters]. Thorax. 2006;61:179-81.
8. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34: 434-40.
9. Schultz KD, Fan LL, Pinsky J, et al. The changing face of empyemas in children: epidemiology and management. Paediatrics. 2004;113:1735-40.
10. Farha T, Thomson AH. The burden of pneumonia in children in the developed world. Paediatr Respir Rev. 2005;6:76-82.
11. Roxburgh CSD, Youngson GG, Townend JA, Turner SW. Trends in pneumonia and empyema in Scottish children in the past 25 years. Arch Dis Child. 2008;93;316-8.
12. Li ST, Tancredi DJ. Empyema Hospitalizations Increased in US Children Despite Pneumococcal Conjugate Vaccine. Pediatrics. 2010;125(1):26-33.
13. Finley C, Clifton J, FitzGerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J. 2008;15(2):85-9.
14. Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington C. Parapneumonic Empyema Death during Past Centaury, Utah. Emerging Infectious Diseases. 2009;15(1):44-8.
15. Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community acquired pneumonia: a validation study. Thorax. 2000;55;219-23.
16. Taryle DA, Potts DE, Sahn SA. The incidence and clinical correlates ofparapneumonic effusions in pneumococcal pneumonia. Chest. 1978;74: 170-3.
17. Hasley PB, Albaum MN, Li YH, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquiredpneumonia? Arch Intern Med. 1996;156:2206-12.
18. Andrews NC, Parker EF, Shaw RP, et al. Management of non-tuberculous empyema. Am Rev Respir Dis. 1962;85:935-6.
19. Heffner JE, Brown LK, Barbieri C, Barbieri C, Deleo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med. 1995;151:1700-8.
20. Kroegel C, Anthony VB. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J. 1997;10:2411-8.
21. Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis. 1991;144:187-94.
22. Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest. 1993;103:1502-7.
23. Civen R, Jousimies-Somer H, Marina M, Borenstein L, Shah H, Finegold SM. A retrospective review of cases of anaerobic empyema and update of bacteriology. Clin Infect Dis. 1995;20(2):S224-9.
24. Chapman SJ, Davies RJ. The management of pleural space infections. Respirology. 2004;9:4-11.
25. Tsang KY, Leung WS, Chan VL, Lin AWL, Chu CM. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes. Hong Kong Med J. 2007;13:178-86.
26. Heffner JE, McDonald J, Barbieri C, Klein J. Management of parapneumonic effusions. An analysis of physician practice patterns. Arch Surg. 1995;130:433-8.
27. Graham EA. Some fundamental considerations in the treatment of empyema thoracis. St. Louis: CV Mosby, 1925;7-110.
28. Davies CWH, Gleeson FV, Davies RJO. BTS guidelines for the management of pleural infection. Thorax. 2003;58:ii18-28.
29. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonis effusions: Evidence-Based Guideline. Chest. 2000;118; 1158-71. [Erratum, Chest 2001;119:319.]
30. Balfour-Lynn IM, Abrahamson E, Cohen G, et al. And on behalf of the Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee. BTS guidelines for the management of pleural infection in children. Thorax. 2005;60:i1-i21.
31. Silverman SG, Mueller PR, Saini S, et al. Thoracic empyema: management with image-guided catheter drainage. Radiology. 1988;169:5-9.
32. Crouch JD, Keagy BA, Delany DJ. "Pigtail" catheter drainage in thoracic surgery. Am Rev Respir Dis. 1987;136:174-5.
33. Ulmer JL, Choplin RH, Reed JC. Image-guided catheter drainage of the infected pleural space. J Thorac Imaging. 1991;6:65-73.
34. Sasse S, Nguyen TK, Mulligan M, Wang N, Mahutte CK, Light RW. The Effects of Early Chest Tube Placement on Empyema Resolution. Chest. 1997;111;1679-83.
35. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest. 1949;28:173-90.
36. Berglin E, Ekroth R, Teger-Nilsson AC, William-Olsson G. Intrapleural instillation of streptokinase. Effects on systemic fibrinolysis. Thorac Cardiovasc Surg. 1981;29:124-6.
37. Maskell NA, Davies RJO. Effusions from parapneumonic infection and empyema. In: Light RW, Lee YCG, eds. Textbook of pleural diseases. London: Arnold. 2003:310-28.
38. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med. 2004;170:49-53.
39. Lee YCG. Ongoing search for effective intrapleural therapy for empyema: is streptokinase the answer? Am J Respir Crit Care Med. 2004;170:1-2.
40. Strange C, Allen ML, Harley R, Lazarchick J, Sahn SA. Intrapleural streptokinase in experimental empyema. Am Rev Respir Dis. 1993;147:962-66.
41. Cameron RJ, Davies HRHR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Systematic Reviews. 2008;2:CD002312.
42. Maskell NA, Davies CWH, Nunn AJ, et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352:865-74.
43. Davies RJO, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52:416-21.
44. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest. 2000; 117:1728-33.
45. Hawthorne ZZML, Guo Y, Drake W, Bilaceroglu S, Misra HL, Light RW. Tissue Plasminogen Activator Combined With Human Recombinant Deoxyribonuclease Is Effective Therapy for Empyema in a Rabbit Model. Chest. 2006;129;1577-83.
46. Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax. 2003;58:365-6.
47. Rahman MM, Maskell N, Davies CWH, et al. Primary result of the second multicentre intrapleural sepsis (MIST2) trial; randomized trial of intrapleural tPA and DNase in pleural infection. Thorax. 2009;64 Suppl IV:A1
48. Molnar TF. Current surgical treatment of thoracic empyema in adults. Eur J Cardiothorac Surg. 2007;32:422-30.
49. Lawrence DR, Ohri KS, Moxon RE, Townsend ER, Fountain SW. Thoracosocopic debridement of empyema thoracis. Ann Thorac Surg. 1997;64:1448-50.
50. Luh SP, Chou MC, Wang LS, Chen JY, Tsai TP. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas. Chest. 2005;127:1427-32.
51. Anstadt MP, Guill CK, Ferguson ER, et al. Surgical versus nonsurgical treatment of empyema thoracis: an outcomes analysis. Am J Med Sci. 2003; 326(1):9-14.
52. Rzyman W, Skokowski J, Romanowicz G, Lass P, Dziadziuszko R. Decortication in chronic pleural empyema-effect on lung function. Eur J Cardiothorac Surg. 2002;21(3):502-7.
53. Regnard JF, Alifano M, Puyo P, Fares E, Magdeleinat P, Levasseur P. Open window thoracostomy followed by intrathoracic flap transposition in the treatment of empyema complicating pulmonary resection. J Thorac Cardiovasc Surg. 2000;120:270-5.
54. Sonnappa S, Cohen G, Owens CM, et al. Comparison of Urokinase and Video-assisted Thoracoscopic Surgery for Treatment of Childhood Empyema. Am J respire crit care med. 2006;174:221-7.
55. St. Peter SD. Tsao K. Harrison C, et al. Thoracoscopic decortication vs. tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg. 2009;44:106-11.